Sodium oxybate

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Revision as of 14:00, September 25, 2020 by Notjusttired (talk | contribs) (create)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Sodium oxybate or gamma-hydroxybutyrate (GHB) is sold under the brand name Xyrem is a restricted prescription drug licensed for the prevention of cataplexy (sudden, brief episodes of loss of muscle strength) and narcolepsy.[1][2]

Prescription sodium oxybate and Xyrem have significant differences from the illegal street drug also known as GHB.[3]

Side effects[edit | edit source]

Learn more[edit | edit source]

See also[edit | edit source]

References[edit | edit source]

  1. ↑ https://www.drugs.com/mtm/sodium-oxybate.html
  2. ↑ https://medlineplus.gov/druginfo/meds/a605032.html
  3. ↑ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2713368/

adverse reaction Any unintended or unwanted response to a treatment, whether in a clinical trial or licensed treatment. May be minor or serious.

Retrieved from "https://me-pedia.org/w/index.php?title=Sodium_oxybate&oldid=84484"